St. Joseph's Health Products

St. Joseph's Health Products specializes in low-dose aspirin formulations focused on enhancing cardiovascular health, offering products that cater to diverse consumer preferences and needs. St. Joseph's Health Products is a company that produces low-dose aspirin designed to support cardiovascular health.

It was acquired by Ilex Consumer Products Group, a portfolio company of JPB Capital Partners, from Johnson & Johnson in January 2011. The company is headquartered in Baltimore, US, and continues to operate under its established brand. St. Joseph Aspirin specializes in low-dose aspirin products designed to support cardiovascular health.

Their core offerings include Safety (Enteric) Coated 81 mg aspirin, which features a specialized coating that allows the tablet to dissolve in the small intestine, thereby reducing gastrointestinal irritation. Additionally, they offer Orange Chewable 81 mg aspirin, catering to those who may have difficulty swallowing pills, providing an alternative with a palatable flavor. These products aim to lower the risk of recurrent heart attacks or strokes for individuals who require aspirin therapy, underscoring their commitment to heart health. St.

Joseph Aspirin products are available in various markets across the United States, targeting consumers who prioritize preventive care and heart health management. St. Joseph Aspirin generates revenue primarily through direct-to-consumer sales and retail partnerships. The company’s products are typically sold in pharmacies, grocery stores, and online platforms, ensuring accessibility to a broad customer base.

Transactions include individual purchases of its flagship offerings, Safety (Enteric) Coated 81 mg aspirin and Orange Chewable 81 mg aspirin, which cater to diverse consumer preferences and needs. While specific pricing details are not disclosed, the overall sales model reflects a straightforward retail structure where customers can buy products on a per-unit basis. The company’s longstanding reputation as a trusted brand in the aspirin market also supports its sales strategy, appealing to families and healthcare providers alike. St.

Joseph's Health Products plans to enhance its product line with new variants of aspirin that are currently under design, although no specific release dates have been announced. The company is also looking to expand its market presence beyond the United States to international regions yet to be specified, with a timeframe for this expansion still to be confirmed. The recent acquisition in January 2011 has positioned the company to utilize its resources effectively, enabling these growth strategies.